Validation of the adult adhd investigator symptom rating scale (AISRS)

Journal of Attention Disorders

Volumn 14, Issue 1, 2010, Pages 57-68

  Spencer, Thomas J ^a   Adler, Lenard A ^b   Qiao, Meihua ^c   Saylor, Keith E ^d   Brown, Thomas E ^e   Holdnack, James A ^f   Schuh, Kory J ^c   Trzepacz, Paula T ^g   Kelsey, Douglas K ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Lilly USA   (United States)

^d NeuroScience Inc   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Harcourt Assessment Inc   (United States)

^g ELI LILLY AND COMPANY   (United States)

Author keywords

Atomoxetine; Attention deficit; Clinical improvement; Hyperactivity

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; PROPYLAMINE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FACTORIAL ANALYSIS; HOSPITALIZATION; HUMAN; IMPULSIVENESS; MIDDLE AGED; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TREATMENT OUTCOME; VALIDATION STUDY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FACTOR ANALYSIS, STATISTICAL; HUMANS; IMPULSIVE BEHAVIOR; MIDDLE AGED; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77953989243     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054709347435     Document Type: Article

References (31)

1. Adler, L.A., Spencer, T., Brown, T.E., Holdnack, J., Saylor, K., Schuh, K.,et al.(2009). Once-daily atomoxetine for Adult ADHD: A six-month, double-blind trial. Journal of Clinical Psychopharmacology, 29, 44-50.
2. Adler, L.A., Spencer, T., Faraone, S.V., Reimherr, F.W., Kelsey, D., Michelson, D.,et al.(2005). Training raters to assess adult ADHD: Reliability of ratings. Journal of Attention Disorders, 8, 121-126.
3. Barkley, R.A. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63, 10-15.
4. Barkley, R.A., Murphy, K.R., & Kwasnik, D. (1996). Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics, 98, 1089-1095.
5. Biederman, J., Faraone, S.V., Spencer, T.J., Mick, E., Monuteaux, M.C., & Aleardi, M. (2006a). Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. Journal of Clinical Psychiatry, 67, 524-540.
6. Biederman, J., Mick, E., Faraone, S., Hammerness, P., Surman, C., Harpold, T.,et al.(2006b). A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: A pilot study. Journal of Clinical Psychopharmacology, 26, 163-166.
7. Biederman, J., Mick, E., Spencer, T., Surman, C., Hammerness, P., Doyle, R.,et al.(2006c). An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectrums, 11, 390-396.
8. Cappelleri, J.C., Althof, S.E., Siegel, R.L., Shpilsky, A., Bell, S.S., & Duttagupta, S. (2004). Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. International Journal of Impotence Research, 16, 30-38.
9. Conners, C.K., Erhardt, D., & Sparrow, E. (1999). Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, New York: Multi-Health Systems.
10. Cronbach, L.J. (1951). Coefficient alpha and the internal consistency of tests. Psychometrika, 16, 297-334.
11. Deyo, R.A., Diehr, P., & Patrick, D.L. (1991). Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials, 12, 142S-158S.
12. Faries, D., & Yalcin, I. (2007). Reliability and validity: Assessing the psychometric properties of rating scales; Pharmaceutical Statistics Using SAS: A Practical Guide (pp. 361-384).Cary, NC: SAS Press.
13. Fossati, A., Di Ceglie, A., Acquarini, E., Donati, D., Donini, M., Novella, L.,et al.(2001). The retrospective assessment of childhood attention deficit hyperactivity disorder in adults: Reliability and validity of the Italian version of the Wender Utah Rating Scale. Comprehensive Psychiatry, 42, 326-336.
14. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P.,et al.(1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 980-988.
15. Kessler, R.C., Adler, L., Barkley, R., Biederman, J., Conners, C.K., Demler, O.,et al.(2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723.
16. Kessler, R.C., Adler, L.A., Gruber, M.J., Sarawate, C.A., Spencer, T., & Van Brunt, D.L. (2007). Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. International Journal of Methods in Psychiatric Research, 16, 52-65.
17. Kunwar, A., Dewan, M., & Faraone, S.V. (2007). Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy, 8, 555-562.
18. La Malfa, G., Lassi, S., Bertelli, M., Pallanti, S., & Albertini, G. (2008). Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability. The use of Conners' Adult ADHD Rating Scales (CAARS). Research in Developmental Disabilities, 29, 158-164.
19. Landgraf, J.M., Rich, M., & Rappaport, L. (2002). Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: Development and evaluation of a new tool. Archives of Pediatric and Adolescent Medicine, 156, 384-391.
20. Lin, L.I. (1989). A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45, 255-268.
21. Mannuzza, S., & Klein, R.G. (2000). Long-term prognosis in attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9, 711-726.
22. McCann, B.S., Scheele, L., Ward, N., & Roy-Byrne, P. (2000). Discriminant validity of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults. Journal of Neuropsychiatry and Clinical Neurosciences, 12, 240-245.
23. Michelson, D., Adler, L., Spencer, T., Reimherr, F.W., West, S.A., Allen, A.J.,et al.(2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53, 112-120.
24. Montgomery, S.A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
25. Reid, R. (1995). Assessment of ADHD with culturally different groups: The use of behaviour rating scales. School Psychology Review, 24, 537-560.
26. Sanchez, M.M., & Binkowitz, B.S. (1999). Guidelines for measurement validation in clinical trial design. Journal of Biopharmaceutical Statistics, 9, 417-438.
27. Secnik, K., Swensen, A., & Lage, M.J. (2005). Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics, 23, 93-102.
28. Spielberger, C.D. (1983). Manual for State-Trait Anxiety Inventory for Adults (STAI). Palo Alto, CA: Consulting Psychologists Press.
29. Stratford, P.W., Binkley, F.M., & Riddle, D.L. (1996). Health status measures: Strategies and analytic methods for assessing change scores. Physical Therapy, 76, 1109-1123.
30. Wender, P.H., Wolf, L.E., & Wasserstein, J. (2001). Adults with ADHD. An overview. Annals of the New York Academy of Sciences, 931, 1-16.
31. Zhang, S., Faries, D.E., Vowles, M., & Michelson, D. (2005). ADHD Rating Scale IV: Psychometric properties from a multinational study as a clinician-administered instrument. Internal Journal of Methods in Psychiatric Research, 14, 186-201.